Article metrics
PDF
Other content recommended for you
- UK government tightens rules on drug trial results
- What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study
- Agency warns of withdrawal risks for patients taking SSRIs
- DTB Select: 5 | May 2015
- The licensing of medicines in the UK
- Is there a cure for corporate crime in the drug industry?
- Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
- Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
- Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
- Did regulators fail over selective serotonin reuptake inhibitors?